TScan Therapeutics Inc

TScan Therapeutics Inc (TCRX) Price Prediction & Forecast

$0.186

+0.005 (+2.53%)At close

Price Predictions

1-Day Price Prediction
+0.25%
1-Week Prediction
-2.55%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

Open in app to unlock longer-horizon forecasts.

Loading chart…

TCRX Prediction & Forecast by Similar Chart Analysis

Alphio's TCRX stock price prediction model matches the current TScan Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.19 (+0.25%). The 1-week path is $0.18 (-2.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy TScan Therapeutics Inc Stock?

TScan Therapeutics Inc (TCRX) is not a good buy right now due to its current price of $0.19, which is significantly below its 52-week high of $1.47 and reflects an 81.73% year-to-date decline. The RSI of 43.9 indicates a lack of momentum, and the recent downgrade by analysts to a price target of $1 raises concerns about future profitability and cash runway. The primary risk is the company's negative earnings trend, with a net income loss of $30.4 million reported in Q2 2026, suggesting ongoing financial challenges.

TCRX stock price ended at $0.19 on Friday, after rising +2.53%

TScan Therapeutics Inc (TCRX) last closed at $0.1864, gaining +2.53%. These facts feed the 1-day and 1-week TCRX price prediction above.

Forecast Drivers

TScan Therapeutics Inc (TCRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Similar Chart Patterns

Stocks whose recent price path most closely matches TCRX, ranked by similarity.

Seasonality analysis for TCRX

Historically the probability of a positive November return for TCRX is 4.55%. April offers the highest probability of a positive month at 64.06%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

10-year price projections for TCRX

MonthMin PriceAvg PriceMax PricePotential ROI
Nov 2026$1.76$2.10$2.47+1025.43%
Dec 2026$1.62$2.10$2.70+1025.43%

In 2026, TScan Therapeutics Inc (TCRX) is projected to range from $1.62 to $2.70.

TScan Therapeutics Inc 2026 monthly forecast

Nov 2026 TCRX forecast
Potential ROI: 1025.43%

In Nov 2026, TScan Therapeutics Inc is projected to average $2.10, with a low of $1.76 and high of $2.47.

Dec 2026 TCRX forecast
Potential ROI: 1025.43%

In Dec 2026, TScan Therapeutics Inc is projected to average $2.10, with a low of $1.62 and high of $2.70.

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading